Influenza A Virus Hemagglutinin (HA) Blocking Peptide

Catalog number
3924BP-50
Name
Influenza A Virus Hemagglutinin (HA) Blocking Peptide
Size
50 μg
Price
245.00 EUR
Supplier

Details

Antibody Target
Influenza A Virus Hemagglutinin (HA)
Accession
ACF76760
Gene ID
NA
Appearance
Colorless liquid
Concentration
0.5 mg/ml
Formulation
50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Packaging
EA
Storage Temp.
-20 °C
Shipping
gel pack
Shelf Life
1 year
Category
HA
Research Use
For Rersearch Use Only! Not to be used in humans.
Handling
The peptide solution should be gently mixed before use.
Virus
influenza
Test
You can block the antibody by the specific target amino acid sequence of peptide.
Properties
blocking peptide
Description
Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.